Cargando…
Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127882/ https://www.ncbi.nlm.nih.gov/pubmed/27730447 http://dx.doi.org/10.1007/s13365-016-0482-z |
| _version_ | 1782470301532028928 |
|---|---|
| author | Campagnolo, Denise Dong, Qunming Lee, Lily Ho, Pei-Ran Amarante, Diogo Koendgen, Harold |
| author_facet | Campagnolo, Denise Dong, Qunming Lee, Lily Ho, Pei-Ran Amarante, Diogo Koendgen, Harold |
| author_sort | Campagnolo, Denise |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5127882 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-51278822016-12-19 Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay Campagnolo, Denise Dong, Qunming Lee, Lily Ho, Pei-Ran Amarante, Diogo Koendgen, Harold J Neurovirol Letter to the Editor Springer International Publishing 2016-10-11 2016 /pmc/articles/PMC5127882/ /pubmed/27730447 http://dx.doi.org/10.1007/s13365-016-0482-z Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Campagnolo, Denise Dong, Qunming Lee, Lily Ho, Pei-Ran Amarante, Diogo Koendgen, Harold Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay |
| title | Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay |
| title_full | Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay |
| title_fullStr | Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay |
| title_full_unstemmed | Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay |
| title_short | Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay |
| title_sort | statistical analysis of pml incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the stratify jcv® dxselect™ antibody assay |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127882/ https://www.ncbi.nlm.nih.gov/pubmed/27730447 http://dx.doi.org/10.1007/s13365-016-0482-z |
| work_keys_str_mv | AT campagnolodenise statisticalanalysisofpmlincidencesofnatalizumabtreatedpatientsfrom2009to2016outcomesafterintroductionofthestratifyjcvdxselectantibodyassay AT dongqunming statisticalanalysisofpmlincidencesofnatalizumabtreatedpatientsfrom2009to2016outcomesafterintroductionofthestratifyjcvdxselectantibodyassay AT leelily statisticalanalysisofpmlincidencesofnatalizumabtreatedpatientsfrom2009to2016outcomesafterintroductionofthestratifyjcvdxselectantibodyassay AT hopeiran statisticalanalysisofpmlincidencesofnatalizumabtreatedpatientsfrom2009to2016outcomesafterintroductionofthestratifyjcvdxselectantibodyassay AT amarantediogo statisticalanalysisofpmlincidencesofnatalizumabtreatedpatientsfrom2009to2016outcomesafterintroductionofthestratifyjcvdxselectantibodyassay AT koendgenharold statisticalanalysisofpmlincidencesofnatalizumabtreatedpatientsfrom2009to2016outcomesafterintroductionofthestratifyjcvdxselectantibodyassay |